hunan hansen pharmaceutica-a
(002412:Shenzhen Stock Exchange)

Financial Statements for hunan hansen pharmaceutica-a (002412)

Currency in Millions of Chinese Renminbi (Yuan)s	As of:	Dec 31 2009 Restated CNY	Dec 31 2010 Restated CNY	Dec 31 2011 Restated CNY	Dec 31 2012 CNY	4 Year Trend
Revenues		283.2	343.4	400.7	489.3
TOTAL REVENUES		283.2	343.4	400.8	489.5
Cost of Goods Sold		67.4	81.6	96.7	123.5
GROSS PROFIT		215.9	261.8	304.1	365.9
Selling General & Admin Expenses, Total		149.8	196.9	241.8	278.4
Other Operating Expenses		4.4	6.8	7.8	9.9
OTHER OPERATING EXPENSES, TOTAL		154.2	203.7	249.6	288.4
OPERATING INCOME		61.7	58.0	54.4	77.6
Interest Expense		-3.7	-1.3	-2.8	-0.6
Interest and Investment Income		0.7	10.3	17.2	17.0
Other Non-Operating Expenses, Total		-0.1	-0.2	-0.2	-0.1
Other Non-Operating Income (Expenses)		-0.1	-0.2	-0.2	-0.1
Gain (Loss) on Sale of Assets		-0.3	-0.1	0.0	-0.1
Other Unusual Items, Total		1.4	6.3	1.0	2.5
EBT, INCLUDING UNUSUAL ITEMS		59.6	73.1	69.5	96.3
Income Tax Expense		10.3	11.1	10.7	14.8
Earnings from Continuing Operations		49.3	62.0	58.8	81.5
NET INCOME		49.3	62.0	58.8	81.5
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		49.3	62.0	58.8	81.5
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		49.3	62.0	58.8	81.5

Report Data Issue

To contact HUNAN HANSEN PHARMACEUTICA-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.